ICML 2019 | Improving the frontline treatment of DLBCL

Umberto Vitolo

Umberto Vitolo, MD, Città della Salute e della Scienza University Hospital, Turin, Italy, discusses the unmet needs in the first-line treatment of diffuse large B-cell lymphoma (DLBCL), and how therapy in the frontline setting can be improved beyond the standard of care, R-CHOP. He highlights how the variety of distinct subtypes of DLBCL should be molecularly targeted. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Share this video